Elevated antiviral, myeloid and endothelial inflammatory markers in severe COVID-19

Ryan S Thwaites, Ashley Sanchez Sevilla Uruchurtu, Matthew Siggins, Felicity Liew, Clark D Russell, Shona C Moore, Edwin Carter, Simon Abrams, Charlotte-Eve Short, Thilipan Thaventhiran, Emma Bergstrom, Zoe Gardener, Stephanie Ascough, Christopher Chiu, Annemarie B Docherty, David Hunt, Yanick J Crow, Tom Solomon, Graham P Taylor, Lance Turtle, Ewen M Harrison, Malcolm G Semple, J Kenneth Baillie, Peter JM Openshaw on behalf of the ISARIC4C investigators
doi: https://doi.org/10.1101/2020.10.08.20209411

Article Information

doi 
https://doi.org/10.1101/2020.10.08.20209411
History 
  • October 13, 2020.
Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.

Author Information

  1. Ryan S Thwaites1,
  2. Ashley Sanchez Sevilla Uruchurtu1,
  3. Matthew Siggins1,
  4. Felicity Liew1,
  5. Clark D Russell2,
  6. Shona C Moore3,
  7. Edwin Carter4,
  8. Simon Abrams3,
  9. Charlotte-Eve Short5,
  10. Thilipan Thaventhiran5,
  11. Emma Bergstrom5,
  12. Zoe Gardener5,
  13. Stephanie Ascough5,
  14. Christopher Chiu5,
  15. Annemarie B Docherty6,7,
  16. David Hunt8,
  17. Yanick J Crow4,
  18. Tom Solomon3,
  19. Graham P Taylor5,
  20. Lance Turtle3,9,
  21. Ewen M Harrison6,
  22. Malcolm G Semple10,11,*,
  23. J Kenneth Baillie7,12,*,
  24. Peter JM Openshaw1,* and
  25. on behalf of the ISARIC4C investigators
  1. 1National Heart and Lung Institute, Imperial College London, U.K.
  2. 2University of Edinburgh Centre for Inflammation Research, Edinburgh, U.K.
  3. 3Dept of Clinical Infection, Microbiology and Immunology, University of Liverpool, U.K.
  4. 4Centre for Genomic and Experimental Medicine, MRC Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh, U.K.
  5. 5Department of Infectious Disease, Faculty of Medicine, Imperial College London, U.K.
  6. 6Centre for Medical Informatics, Usher Institute, University of Edinburgh, Edinburgh, U.K.
  7. 7Intensive Care Unit, Royal Infirmary Edinburgh, Edinburgh, U.K.
  8. 8Centre for Clinical Brain Sciences, University of Edinburgh, Edinburgh, U.K.
  9. 9Tropical and infectious disease unit, Liverpool University Hospitals NHS Foundation Trust (member of Liverpool Health Partners), U.K.
  10. 10NIHR Health Protection Research Unit in Emerging and Zoonotic Infections and Institute of Translational Medicine, Faculty of Health and Life Sciences, University of Liverpool, Liverpool, U.K.
  11. 11Respiratory Medicine, Alder Hey Children’s Hospital, Institute in The Park, University of Liverpool, Alder Hey Children’s Hospital, Liverpool, U.K.
  12. 12Roslin Institute, University of Edinburgh, Edinburgh, U.K.
  1. ↵*joint corresponding authors p.openshaw{at}imperial.ac.uk
Back to top
Posted October 13, 2020.
Download PDF
Data/Code
Email
Elevated antiviral, myeloid and endothelial inflammatory markers in severe COVID-19
Ryan S Thwaites, Ashley Sanchez Sevilla Uruchurtu, Matthew Siggins, Felicity Liew, Clark D Russell, Shona C Moore, Edwin Carter, Simon Abrams, Charlotte-Eve Short, Thilipan Thaventhiran, Emma Bergstrom, Zoe Gardener, Stephanie Ascough, Christopher Chiu, Annemarie B Docherty, David Hunt, Yanick J Crow, Tom Solomon, Graham P Taylor, Lance Turtle, Ewen M Harrison, Malcolm G Semple, J Kenneth Baillie, Peter JM Openshaw
medRxiv 2020.10.08.20209411; doi: https://doi.org/10.1101/2020.10.08.20209411
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area